BioCentury
ARTICLE | Company News

Adocia, Eli Lilly deal

August 5, 2013 7:00 AM UTC

The companies mutually terminated a December 2011 deal to develop and commercialize a version of Lilly's Humalog insulin lispro that uses Adocia's BioChaperone polymer technology. Adocia, which retai...